Related Experiment Video
Updated: Jul 26, 2026

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Measuring morbidity from asthma in children
E A Mitchell1, A W Stewart, H H Rea
1University of Auckland.
Insights
New asthma morbidity measures effectively assess severity in children. These tools, including parental perception and emotional response, correlate well with traditional metrics and school attendance, aiding clinical assessment and research.
Area of Science:
- Pediatric Pulmonology
- Clinical Assessment Tools
- Asthma Research
Background:
- Traditional measures of childhood asthma morbidity, such as hospital admissions and emergency room visits, may not fully capture the spectrum of illness, especially in milder cases.
- Accurate assessment of asthma severity is crucial for effective management and intervention in pediatric populations.
Purpose of the Study:
- To develop and validate novel measures of asthma morbidity applicable to children across all severity grades.
- To create a composite score reflecting parental perception and emotional response to a child's asthma.
Main Methods:
- A cross-sectional study involving 381 children with asthma.
- Comparison of traditional asthma morbidity indicators (hospital admissions, ER visits) with new measures (school attendance, parental perception, parent emotional response).
Main Results:
- Poor school attendance was significantly associated with severe asthma based on traditional measures (r = 0.30, p < 0.0001).
- A new composite morbidity score, derived from parental perception and emotional response, demonstrated strong correlations with traditional morbidity scores (r = 0.43, p < 0.0001) and school attendance (r = 0.28, p < 0.0001).
Conclusions:
- The newly developed asthma morbidity measures are practical and user-friendly.
- These measures are valuable for assessing asthma severity, particularly in mild to moderate cases, and are recommended for clinical and research settings.
Aims:
To develop new measures of asthma morbidity which would be applicable to children with asthma of all grades of severity.
Methods:
This study used a cross sectional sample of asthmatic children. Traditional asthma morbidity measures (admission to hospital, use of Emergency Room, general practitioner, after hours deputising service and ambulance) were compared with new measures (school attendance, teacher assessment, parental perception of morbidity and parents emotional response to child's asthma).
Results:
Data was obtained for 381 children with asthma. Children with poor school attendance were found in the severe group as judged by a composite score using traditional measures (r = 0.30, p < 0.0001). A new composite morbidity score based on two questions about parental perception of severity (how often has asthma prevented participation in activities and rating of severity of asthma in general over the last year) and two questions about parent emotional response to the child's asthma (how often has your child's asthma (a) made you feel frightened and (b) stopped family activities) was developed. This new measure of asthma morbidity was correlated with the composite score using traditional morbidity measures (r = 0.43, p < 0.0001) and with school attendance (r = 0.28, p < 0.0001).
Conclusion:
These new morbidity measures are quick and easy to use, and provide an opportunity to measure asthma severity at the moderate to mild end of the severity spectrum. We recommend their use for both clinical assessment and research.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma I: Introduction
Asthma III: Clinical Manifestations

